68 results
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
7 Mar 24
Chemomab Therapeutics Announces Year End and Fourth Quarter 2023 Financial Results
7:00am
), a clinical stage biotechnology company focused on the discovery and development of innovative therapeutics for fibro-inflammatory diseases … later this month.
About Chemomab Therapeutics Ltd.
Chemomab is a clinical stage biotechnology company developing innovative therapeutics for fibro
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
3 Jan 24
Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary
7:00am
Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company focused on the discovery and development of innovative therapeutics … are based, except as required by law.
About Chemomab Therapeutics Ltd.
Chemomab is a clinical stage biotechnology company developing innovative
6-K
EX-99.2
CMMB
Chemomab Therapeutics Ltd
9 Nov 23
Current report (foreign)
8:00am
and development of innovative therapeutics for fibro-inflammatory diseases with high unmet need, today reported financial and operating results for the third … biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need. Based on the unique and pivotal role of CCL24
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
9 Nov 23
Current report (foreign)
8:00am
is located in Kiryat Atidim, Tel Aviv, Israel. The Company is a clinical-stage biotech company discovering and developing innovative therapeutics
F-3/A
93fau e7wvbm
30 Oct 23
Shelf registration (foreign) (amended)
8:33am
F-3
39y7vt
16 Oct 23
Shelf registration (foreign)
4:25pm
6-K
EX-99.2
shlnxme52aq
14 Aug 23
Current report (foreign)
8:05am
6-K
EX-99.1
agm63p el
14 Aug 23
Current report (foreign)
8:05am
6-K
EX-99.3
4rp ytbfvi6
14 Aug 23
Current report (foreign)
8:05am
8-K
EX-99.1
i9qt7v5m7j9
5 Jun 23
Chemomab Therapeutics Announces Executive Leadership Changes and Provides a Corporate Update
7:00am
8-K
EX-99.1
6bwlz60o
11 May 23
Chemomab Therapeutics Announces First Quarter 2023 Financial Results and Provides a Corporate Update
6:10am
8-K
EX-99.1
u80ilpyihgw9gcr4
14 Nov 22
Chemomab Announces Appointment of Matthew Frankel, MD, MBA
4:06pm
8-K
EX-99.1
cjksx 5hapjxsqw06h8i
12 Aug 22
Chemomab Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
7:08am
8-K
EX-99.1
xiq86d j6375813k
21 Jun 22
Chemomab Therapeutics Appoints Jill M. Quigley, JD, to Its Board of Directors
7:00am